http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101666247-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 |
| filingDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101666247-B1 |
| titleOfInvention | Novel pyranopyrandione compounds or pharmaceutically acceptable salts thereof, process for preparing thereof and pharmaceutical composition comprising the same for treating disease derived from allergic inflammatory response |
| abstract | The present invention relates to a novel pyran pyranthione compound, or a pharmaceutically acceptable salt thereof, a process for producing the same, and a pharmaceutical composition for treating an allergic inflammatory reaction-related disease. The novel pyran pyranthione compound of the present invention suppresses the production of eotaxin in proportion to the dose without exhibiting toxicity to the cells and exhibits an asthma treatment effect so that it can be widely used for the development of a more effective asthma treatment agent . |
| priorityDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.